We've found
14,731
archived clinical trials in
Psychiatric
We've found
14,731
archived clinical trials in
Psychiatric
Optimizing Resilience and Coping in HIV Via Internet Delivery
Updated: 8/15/2014
Optimizing Resilience and Coping in HIV Via Internet Delivery
Status: Enrolling
Updated: 8/15/2014
Optimizing Resilience and Coping in HIV Via Internet Delivery
Updated: 8/15/2014
Optimizing Resilience and Coping in HIV Via Internet Delivery
Status: Enrolling
Updated: 8/15/2014
Click here to add this to my saved trials
Developing Cognitive Training for Tourette Syndrome
Updated: 8/18/2014
Developing Effective Response Inhibition Training for Symptom Relief in Tourette Syndrome
Status: Enrolling
Updated: 8/18/2014
Developing Cognitive Training for Tourette Syndrome
Updated: 8/18/2014
Developing Effective Response Inhibition Training for Symptom Relief in Tourette Syndrome
Status: Enrolling
Updated: 8/18/2014
Click here to add this to my saved trials
Two Anger Management Programs for Teens.
Updated: 8/21/2014
An Exploratory Study of Two Intervention Programs for Anger Management for Teens.
Status: Enrolling
Updated: 8/21/2014
Two Anger Management Programs for Teens.
Updated: 8/21/2014
An Exploratory Study of Two Intervention Programs for Anger Management for Teens.
Status: Enrolling
Updated: 8/21/2014
Click here to add this to my saved trials
Two Anger Management Programs for Teens.
Updated: 8/21/2014
An Exploratory Study of Two Intervention Programs for Anger Management for Teens.
Status: Enrolling
Updated: 8/21/2014
Two Anger Management Programs for Teens.
Updated: 8/21/2014
An Exploratory Study of Two Intervention Programs for Anger Management for Teens.
Status: Enrolling
Updated: 8/21/2014
Click here to add this to my saved trials
An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder
Updated: 8/25/2014
An Exploratory Open-Label Phase 2 Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 8/25/2014
An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder
Updated: 8/25/2014
An Exploratory Open-Label Phase 2 Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 8/25/2014
Click here to add this to my saved trials
Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents With Autism Spectrum Disorders
Updated: 9/17/2014
Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents With Autism Spectrum Disorders
Status: Enrolling
Updated: 9/17/2014
Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents With Autism Spectrum Disorders
Updated: 9/17/2014
Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents With Autism Spectrum Disorders
Status: Enrolling
Updated: 9/17/2014
Click here to add this to my saved trials
Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents With Autism Spectrum Disorders
Updated: 9/17/2014
Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents With Autism Spectrum Disorders
Status: Enrolling
Updated: 9/17/2014
Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents With Autism Spectrum Disorders
Updated: 9/17/2014
Magnetic Resonance Spectroscopic and Diffusion Tensor Imaging of Adolescents With Autism Spectrum Disorders
Status: Enrolling
Updated: 9/17/2014
Click here to add this to my saved trials
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Click here to add this to my saved trials
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Click here to add this to my saved trials
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Click here to add this to my saved trials
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Click here to add this to my saved trials
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Click here to add this to my saved trials
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Click here to add this to my saved trials
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Click here to add this to my saved trials
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Click here to add this to my saved trials
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Click here to add this to my saved trials
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Bioavailability of LY03004 and Risperdal® Consta®
Updated: 9/17/2014
A Randomized, Open-Label, Parallel-Group Study to Assess the Relative Bioavailability of LY03004 and Risperdal® Consta® at 25 mg Following Multiple Intramuscular Injections in Stable Patients With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/17/2014
Click here to add this to my saved trials
Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging
Updated: 9/19/2014
Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging
Status: Enrolling
Updated: 9/19/2014
Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging
Updated: 9/19/2014
Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging
Status: Enrolling
Updated: 9/19/2014
Click here to add this to my saved trials
Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder
Updated: 9/24/2014
Single Site, Open Label Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder.
Status: Enrolling
Updated: 9/24/2014
Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder
Updated: 9/24/2014
Single Site, Open Label Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder.
Status: Enrolling
Updated: 9/24/2014
Click here to add this to my saved trials
Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)
Updated: 9/24/2014
A Double-Blind, Placebo-Controlled Random Order Crossover Study of Iloperidone for Symptoms of Arousal in PTSD Including Insomnia and Irritability.
Status: Enrolling
Updated: 9/24/2014
Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)
Updated: 9/24/2014
A Double-Blind, Placebo-Controlled Random Order Crossover Study of Iloperidone for Symptoms of Arousal in PTSD Including Insomnia and Irritability.
Status: Enrolling
Updated: 9/24/2014
Click here to add this to my saved trials
Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
Updated: 9/29/2014
Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
Status: Enrolling
Updated: 9/29/2014
Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
Updated: 9/29/2014
Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Updated: 9/29/2014
A Randomized, Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Prevention of Recurrence in Subjects With Bipolar I Disorder
Status: Enrolling
Updated: 9/29/2014
Click here to add this to my saved trials
Home-Based Program to Help Parents of Drug Abusing Adolescents
Updated: 10/2/2014
Parents as Interventionists for Moderate Drug Abusing Adolescents
Status: Enrolling
Updated: 10/2/2014
Home-Based Program to Help Parents of Drug Abusing Adolescents
Updated: 10/2/2014
Parents as Interventionists for Moderate Drug Abusing Adolescents
Status: Enrolling
Updated: 10/2/2014
Click here to add this to my saved trials
"ACT" for Parents of Children With Autism Spectrum Disorder
Updated: 10/2/2014
Taking ACTion: Acceptance and Commitment Therapy for Parents of Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 10/2/2014
"ACT" for Parents of Children With Autism Spectrum Disorder
Updated: 10/2/2014
Taking ACTion: Acceptance and Commitment Therapy for Parents of Children With Autism Spectrum Disorder
Status: Enrolling
Updated: 10/2/2014
Click here to add this to my saved trials
Open Label Clinical Trial of Vitamin D in Children With Autism
Updated: 10/20/2014
Open Label Clinical Trial of Vitamin D Dosage Tolerability, and Effect on Behavioral Measures in Children With Autism
Status: Enrolling
Updated: 10/20/2014
Open Label Clinical Trial of Vitamin D in Children With Autism
Updated: 10/20/2014
Open Label Clinical Trial of Vitamin D Dosage Tolerability, and Effect on Behavioral Measures in Children With Autism
Status: Enrolling
Updated: 10/20/2014
Click here to add this to my saved trials